Page results
-
The Central Venous Access Device team provides a nurse-led service to teenagers and adults who have been referred to UCLH for cancer treatment.
-
This page aims to help you, your family or carers to plan ahead, and talk about decisions about your care or treatment that may need to be made in the future.
-
At UCLH we use many different drugs to treat patients with cancer. Chemotherapy is the treatment of cancer with drugs designed to control or destroy the growth of the tumour.
-
Patient information for patients who are having a bone marrow biopsy.
-
Information about sickle cell disorder and pregnancy for UCLH patients.
-
This page explains the type of care we offer in the Supportive Care Unit at the University College Hospital Macmillan Cancer Centre.
-
The Interventional Oncology Service (IOS) at University College London Hospital (UCLH) is committed to improving the experience and outcomes for patients with cancer through cutting edge image guided interventions.
-
Critical care incorporates general adult intensive care, high-dependency, the Post-Anaesthetic Care Unit (PACU), critical care outreach and the Critical Care Follow-up Clinic.
-
This page gives advice for those wanting to refer patients for nuclear medicine investigations at University College London Hospitals NHS Foundation Trust. Given at the end of this page are appropriate referral guidelines for the tests we perform.
-
The Royal National ENT and Eastman Dental Hospitals is one of the UK's largest centres for ENT surgery, it offers a wide range of services from a multidisciplinary team. The ENT out-patient department provides both routine and specialist clinics including some nurse-led clinics. Referral to this service is via your GP.
File results
-
FOI/2023/0295 - Strikes and Trust use of the BMA rate card
-
FOI/2023/0296 - Consultant workforce information
-
FOI/2023/0300 - Post-mortem examinations for 2019, 2020, 2021 and 2022
-
FOI/2023/0301 - Meat served at the Trust that may contain nitrates or nitrites
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust